Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Aclidinium
DRUG
2 trials
Sponsors
Sunovion Respiratory Development Inc.
, University of Dundee
Conditions
COPD
Pulmonary Disease, Chronic Obstructive
Phase 2
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
Completed
NCT02038829
Sunovion Respiratory Development Inc.
COPD
Start: 2014-01-31
End: 2014-05-31
Updated: 2018-04-10
Phase 4
Evaluation of Long-Acting Muscarinic Antagonists in COPD
Completed
NCT02039050
University of Dundee
Pulmonary Disease, Chronic Obstructive
Start: 2014-02-28
End: 2015-07-31
Updated: 2019-04-12
Related Papers
Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
UNC Libraries
2019-08-18
Dose selection for glycopyrrolate/eFlow<sup>®</sup> phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies.
2017-12-04
8 citations